Efficacy of Activated protein C to treat Diabetic Leg ulcers - a randomised, controlled clinical trial

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1032549

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Chronic leg ulcers are a major public health burden. Research undertaken by the CIs and funded by a NHMRC Development Grant have shown that activated protein C heals chronic wounds in animals and now in humans, and resolved mechanisms underlying activated protein C's actions. The current chronic leg ulcer trial is an essential step to validate the therapeutic use of activated protein C in wound healing, which is likely to emerge as a cost-effective treatment for this difficult health problem.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $519,284.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

chronic leg or foot ulcers | diabetes | diabetic complications | wound healing | wound repair

Related Links